Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-01-10

FDA Approved: GABAPENTIN — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for gabapentin from Aurobindo Pharma Limited, marking a supplemental approval for this generic gabapentin product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

SUPPL AP for GABAPENTIN (GABAPENTIN)